OpenVSafe by OpenVAERS
Search V-safe

52B-89600-31844

2 vaccinations 3 coded responses 18 check-ins 3 free-text entries 0 call cases
Sex
Female
Age at first dose
05-11
ZIP prefix
033 / NH
Registered
2021-12-01
Relationship
Child or adolescent in my care
Guardian
3EP-11034-84999
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-11-22
    Dose 1 — Pfizer-BioNTech
  2. 2021-12-01
    Registered in v-safe
  3. 2021-12-01
    Health check-in — day 7, dose 1, dependent
    Feeling: Good · None
    Adult check-in
  4. 2021-12-06
    Health check-in — day 14, dose 1, dependent
    Feeling: Good
    Adult check-in
  5. 2021-12-13
    Health check-in — day 21, dose 1, dependent
    Feeling: Good
    Adult check-in
  6. 2021-12-14
    Dose 2 — Pfizer-BioNTech
  7. 2021-12-15
    Health check-in — days 1–6 daily, dose 2, dependent
    Feeling: Fair · Site: Pain, Swelling · Fever · Chills, Muscle or body aches, Fatigue or tiredness, Abdominal pain · Be unable to work or attend school
    Adult check-in
  8. 2021-12-16
    Health check-in — days 1–6 daily, dose 2, dependent
    Feeling: Good · Site: Pain · Fatigue or tiredness
    Adult check-in
  9. 2021-12-17
    Health check-in — days 1–6 daily, dose 2, dependent
    Feeling: Good · None
    Adult check-in
  10. 2021-12-18
    Health check-in — days 1–6 daily, dose 2, dependent
    Feeling: Good · None
    Adult check-in
  11. 2021-12-19
    Health check-in — days 1–6 daily, dose 2, dependent
    Feeling: Good · None
    Adult check-in
  12. 2021-12-20
    Health check-in — days 1–6 daily, dose 2, dependent
    Feeling: Good · None
    Adult check-in
  13. 2021-12-23
    Health check-in — day 7, dose 2, dependent
    Feeling: Good · None
    Adult check-in
  14. 2021-12-29
    Health check-in — day 14, dose 2, dependent
    Feeling: Good
    Adult check-in
  15. 2022-01-06
    Health check-in — day 21, dose 2, dependent
    Feeling: Good
    Adult check-in
  16. 2022-01-11
    Survey response — day 28, dose 2, dependent
    MedDRA: Headache, Lymphadenopathy, Pyrexia, SARS-CoV-2 test negative — Feeling: Good · Be unable to work or attend school
    Free text: Headache, swollen lymph nodes, fever. COVID negative x2, symptoms now resolved.
    MedDRA releases: 2024-11 · check-in free text available
  17. 2022-01-18
    Health check-in — day 35, dose 2, dependent
    Feeling: Good
    Adult check-in
  18. 2022-01-25
    Health check-in — day 42, dose 2, dependent
    Feeling: Good
    Adult check-in
  19. 2022-03-15
  20. 2022-06-14
    Survey response — 6 months, dose 2, dependent
    MedDRA: COVID-19 — Feeling: Good · Be unable to work or attend school
    Free text: COVID-19
    MedDRA releases: 2024-11 · check-in free text available
  21. 2022-12-16
    Survey response — 12 months, dose 2, dependent
    MedDRA: Gastrointestinal viral infection — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: GI bug
    MedDRA releases: 2024-11 · check-in free text available

Vaccinations

DoseDateManufacturerCo-administered
12021-11-22Pfizer-BioNTech No
22021-12-14Pfizer-BioNTech No

Free text

Release 10 — day 28, dose 2, dependent

2022-01-11

Symptoms: Headache, swollen lymph nodes, fever. COVID negative x2, symptoms now resolved.

Release 12 — 6 months, dose 2, dependent

2022-06-14

Symptoms: COVID-19

Release 12 — 12 months, dose 2, dependent

2022-12-16

Symptoms: GI bug

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDCOVID-19 · · ✓
SDGastrointestinal viral infection · · ✓
SDHeadache · · ✓
SDLymphadenopathy · · ✓
SDPyrexia · · ✓
SDSARS-CoV-2 test negative · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release